HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

Background: Breast cancer in very young women (BCVY) defined as <35 years old, presents with different molecular biology than in older patients. High HDAC5 expression has been associated with poor prognosis in breast cancer (BC) tissue. We aimed to analyze HDAC5 expression in BCVY and older patie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Oltra, Sara S., Cejalvo, Juan Miguel, Tormo, Eduardo, Albanell, Marta, Ferrer, Ana, Nacher, Marta, Bermejo, Begoña, Hernando, Cristina, Chirivella, Isabel, Alonso, Elisa, Burgués, Octavio, Peña-Chilet, Maria, Eroles, Pilar, Lluch, Ana, Ribas, Gloria, Martinez, María Teresa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072585/
https://ncbi.nlm.nih.gov/pubmed/32050699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020412
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak